BeiGene Historical Financial Ratios
| BGNE Stock | USD 190.51 4.05 2.08% |
BeiGene is presently reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 4.02 or Days Sales Outstanding of 63.47 will help investors to properly organize and evaluate BeiGene financial condition quickly.
BeiGene |
About BeiGene Financial Ratios Analysis
BeiGeneFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BeiGene investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BeiGene financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BeiGene history.
BeiGene Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing BeiGene stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BeiGene sales, a figure that is much harder to manipulate than other BeiGene multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Most ratios from BeiGene's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Days Of Inventory On Hand is projected to increase significantly based on the last few years of reporting. The current year's Days Payables Outstanding is expected to grow to 317.87, whereas PTB Ratio is forecasted to decline to 4.02.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 9.67 | 6.54 | 1.21 | 1.15 | Days Of Inventory On Hand | 54.53 | 53.48 | 399.78 | 419.77 |
BeiGene fundamentals Correlations
Click cells to compare fundamentals
BeiGene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BeiGene fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 23.25 | 69.83 | 21.37 | 16.02 | 7.66 | 7.27 | |
| Ptb Ratio | 10.17 | 5.57 | 4.03 | 5.17 | 5.32 | 4.02 | |
| Days Sales Outstanding | 60.42 | 94.15 | 155.2 | 44.64 | 58.77 | 63.47 | |
| Book Value Per Share | 16.29 | 46.35 | 67.28 | 42.5 | 33.89 | 22.46 | |
| Free Cash Flow Yield | (0.0913) | (0.0701) | (0.0642) | (0.0867) | (0.0924) | (0.097) | |
| Operating Cash Flow Per Share | (12.49) | (15.38) | (14.0) | (14.51) | (11.09) | (11.64) | |
| Stock Based Compensation To Revenue | 0.31 | 0.59 | 0.2 | 0.21 | 0.15 | 0.14 | |
| Capex To Depreciation | 8.52 | 7.2 | 6.78 | 7.08 | 6.63 | 5.7 | |
| Pb Ratio | 10.17 | 5.57 | 4.03 | 5.17 | 5.32 | 4.02 | |
| Ev To Sales | 22.45 | 67.17 | 18.24 | 13.92 | 6.75 | 6.41 | |
| Free Cash Flow Per Share | (15.13) | (18.12) | (17.39) | (19.06) | (16.66) | (17.49) | |
| Roic | (0.35) | (0.79) | (0.37) | (0.21) | (0.29) | (0.28) | |
| Inventory Turnover | 34.97 | 15.29 | 6.69 | 6.82 | 0.91 | 0.87 | |
| Net Income Per Share | (15.83) | (19.17) | (15.23) | (19.43) | (8.45) | (8.87) | |
| Days Of Inventory On Hand | 10.44 | 23.87 | 54.53 | 53.48 | 399.78 | 419.77 | |
| Payables Turnover | 8.15 | 5.89 | 9.67 | 6.54 | 1.21 | 1.15 | |
| Research And Ddevelopement To Revenue | 2.17 | 4.19 | 1.24 | 1.16 | 0.72 | 0.69 | |
| Capex To Revenue | 0.37 | 0.74 | 0.27 | 0.33 | 0.24 | 0.22 | |
| Cash Per Share | 16.36 | 55.72 | 71.32 | 43.97 | 30.41 | 20.49 | |
| Pocfratio | (13.27) | (16.8) | (19.36) | (15.16) | (16.27) | (15.45) | |
| Capex To Operating Cash Flow | (0.21) | (0.18) | (0.24) | (0.31) | (0.5) | (0.48) | |
| Pfcf Ratio | (10.95) | (14.26) | (15.58) | (11.54) | (10.83) | (10.29) | |
| Days Payables Outstanding | 44.77 | 62.0 | 37.76 | 55.84 | 302.74 | 317.87 | |
| Income Quality | 0.81 | 0.79 | 0.8 | 0.92 | 1.31 | 1.38 | |
| Roe | (0.97) | (0.41) | (0.23) | (0.46) | (0.25) | (0.26) | |
| Ev To Operating Cash Flow | (12.81) | (16.17) | (16.52) | (13.17) | (14.33) | (13.61) | |
| Pe Ratio | (10.47) | (13.48) | (17.79) | (11.32) | (21.35) | (22.42) | |
| Ev To Free Cash Flow | (10.58) | (13.72) | (13.3) | (10.02) | (9.54) | (9.06) | |
| Earnings Yield | (0.0955) | (0.0742) | (0.0562) | (0.0883) | (0.0468) | (0.0492) | |
| Intangibles To Total Assets | 0.0328 | 0.009613 | 0.012 | 0.0148 | 0.009842 | 0.019 | |
| Net Debt To E B I T D A | 0.36 | 0.5 | 2.64 | 1.72 | 1.99 | 2.09 | |
| Current Ratio | 4.1 | 4.61 | 4.76 | 4.63 | 2.32 | 3.77 | |
| Tangible Book Value Per Share | 15.41 | 45.71 | 66.17 | 41.58 | 33.34 | 21.98 | |
| Receivables Turnover | 6.04 | 3.88 | 2.35 | 8.18 | 6.21 | 6.05 | |
| Graham Number | 76.17 | 141.42 | 151.86 | 136.31 | 80.25 | 54.17 | |
| Shareholders Equity Per Share | 16.29 | 46.35 | 67.28 | 42.5 | 33.89 | 18.79 | |
| Debt To Equity | 0.11 | 0.26 | 0.14 | 0.1 | 0.13 | 0.27 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.19) | Revenue Per Share 225.239 | Quarterly Revenue Growth 0.395 | Return On Assets (0.1) | Return On Equity (0.23) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.